CINECA IRIS Institutional Research Information System

RESTANTE, GIULIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.068
AS - Asia 764
EU - Europa 646
SA - Sud America 99
Continente sconosciuto - Info sul continente non disponibili 90
AF - Africa 58
OC - Oceania 11
Totale 3.736
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.974
SG - Singapore 279
IT - Italia 241
CN - Cina 190
HK - Hong Kong 111
SE - Svezia 91
BR - Brasile 81
VN - Vietnam 74
DE - Germania 69
CA - Canada 60
GB - Regno Unito 59
BG - Bulgaria 52
FR - Francia 41
CI - Costa d'Avorio 32
IN - India 22
FI - Finlandia 20
RU - Federazione Russa 18
JP - Giappone 17
AT - Austria 15
TR - Turchia 14
BD - Bangladesh 13
MX - Messico 10
AU - Australia 9
PL - Polonia 8
NG - Nigeria 7
NL - Olanda 7
AR - Argentina 6
CR - Costa Rica 6
KR - Corea 6
SN - Senegal 6
BE - Belgio 5
IL - Israele 5
IQ - Iraq 5
PK - Pakistan 5
ES - Italia 4
ZA - Sudafrica 4
BF - Burkina Faso 3
EC - Ecuador 3
GR - Grecia 3
JM - Giamaica 3
JO - Giordania 3
LB - Libano 3
LT - Lituania 3
VE - Venezuela 3
BB - Barbados 2
CL - Cile 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
KE - Kenya 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PR - Porto Rico 2
TW - Taiwan 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AI - Anguilla 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
DK - Danimarca 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
KZ - Kazakistan 1
LV - Lettonia 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
UY - Uruguay 1
Totale 3.646
Salva come PNG Salva come JPEG
Città #
Ashburn 223
Fairfield 172
Singapore 135
Houston 131
Woodbridge 114
Hong Kong 108
Santa Clara 105
San Jose 101
Chandler 98
Dallas 78
Seattle 78
Cambridge 57
Sofia 52
Serra 47
Los Angeles 46
Wilmington 46
Shanghai 43
New York 41
Pisa 41
Beijing 40
London 36
Boardman 35
Abidjan 32
Ann Arbor 32
Princeton 30
Council Bluffs 28
Florence 27
Frankfurt am Main 25
Ottawa 22
Lawrence 20
Lauterbourg 19
Chicago 18
Ho Chi Minh City 18
Munich 18
Medford 17
Tokyo 13
Vienna 13
Buffalo 12
Dearborn 12
Istanbul 12
Dong Ket 11
Milan 10
Montreal 10
São Paulo 10
Turin 10
Turku 10
Des Moines 9
Helsinki 9
Toronto 9
Columbus 8
Hanoi 8
Redondo Beach 8
Boulder 7
Lagos 7
Nanjing 7
Orem 7
San Francisco 7
Warsaw 7
Brasília 6
Dakar 6
Fuzhou 6
Iowa City 6
Nuremberg 6
Paris 6
Redwood City 6
San Diego 6
Bremen 5
Brooklyn 5
Cascina 5
Chennai 5
Chiesina Uzzanese 5
Guangzhou 5
Kunming 5
Washington 5
Brussels 4
Denver 4
Hefei 4
Norwalk 4
Phoenix 4
Quanzhou 4
San José 4
Dhaka 3
Johannesburg 3
Kingston 3
La Spezia 3
Lahore 3
Manchester 3
Mexico City 3
Philadelphia 3
Pistoia 3
Queens 3
Rome 3
Abbeville 2
Amman 2
Baoding 2
Bientina 2
Boston 2
Bridgetown 2
Campinas 2
Can Tho 2
Totale 2.514
Salva come PNG Salva come JPEG
Nome #
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC 354
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response 220
Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment 201
Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy 194
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment 193
Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide 189
Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib Treatment 188
Critical focus on mechanisms of resistance and toxicity of m-TOR inhibitors in pancreatic neuroendocrine tumors 187
Pharmacogenetics and metabolism from science to implementation in clinical practice: the example of dihydropyrimidine dehydrogenase. 182
Implications of KRAS mutations in acquired resistance to treatment in NSCLC 182
Unusual gastrointestinal and cutaneous toxicities by bleomycin, etoposide, and cisplatin: A case report with pharmacogenetic analysis to personalize treatment 174
Pharmacogenetics of androgen signaling in prostate cancer: focus on castration resistance and predictive biomarkers of response to treatment 174
From the beginning to resistance: study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC 174
Genome Wide Association Studies (GWAS) 166
Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring 163
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy 162
Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA 147
Erratum: Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers 141
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers 139
Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells 136
null 70
Totale 3.736
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.120
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022183 0 0 0 0 40 37 8 6 14 7 9 62
2022/2023364 36 54 27 16 32 37 1 30 93 1 35 2
2023/2024233 15 14 46 10 19 47 6 6 3 14 30 23
2024/2025692 11 21 10 45 83 66 40 57 75 85 72 127
2025/2026824 59 87 55 119 127 46 143 32 53 71 25 7
2026/2027353 33 54 116 120 30 0 0 0 0 0 0 0
Totale 3.736